山东新华制药股份有限公司

投资者关系

信息透明，信任同行

2025-05-19

Overseas Regulatory Announcement-Announcement on Icosapent Ethyl Having Obtained the Notification of Approval of Marketing Application for Chemical Substance Drugs

2025-05-19

海外監管公告-關於二十碳五烯酸乙酯獲得化學原料藥上市申請批准通知書的公告

2025-05-12

海外監管公告-關於參加2025年山東轄區上市公司投資者網上集體接待日活動的公告

2025-05-09

Overseas Regulatory Announcement- Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information

2025-05-09

海外監管公告-關於獲得《藥品補充申請批准通知書》等相關情況的公告

2025-05-06

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2025

2025-05-06

截至二零二五年四月三十日止月份之股份發行人的證券變動月報表

2025-04-28

2-1临时公告海外監管公告-董事會決議公告、2025年一季度報告

2025-04-28

Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information

2025-04-28

海外監管公告-關於獲得《藥品補充申請批准通知書》等相關情況的公告